Abbvie Stock Performance


USD 134.21  4.11  2.97%   

The firm shows a Beta (market volatility) of 0.6128, which signifies possible diversification benefits within a given portfolio. Let's try to break down what Abbvie's beta means in this case. As returns on the market increase, Abbvie returns are expected to increase less than the market. However, during the bear market, the loss on holding Abbvie will be expected to be smaller as well. Even though it is essential to pay attention to Abbvie Inc historical returns, it is always good to be careful when utilizing equity current trending patterns. Our philosophy in foreseeing any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Abbvie Inc exposes twenty-one different technical indicators, which can help you to evaluate its performance. Abbvie Inc has an expected return of -0.14%. Please be advised to confirm Abbvie Inc coefficient of variation, as well as the relationship between the treynor ratio and semi variance to decide if Abbvie Inc performance from the past will be repeated at some point in the near future.
Abbvie Performance
0 of 100
Over the last 90 days Abbvie Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's fundamental drivers remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors. ...more

Abbvie Price Channel

Fifty Two Week Low106.86
Target High Price200.00
Fifty Two Week High175.91
Payout Ratio76.18%
Trailing Annual Dividend Yield2.53%
Target Low Price135.00

Abbvie Relative Risk vs. Return Landscape

If you would invest  15,253  in Abbvie Inc on July 6, 2022 and sell it today you would lose (1,421)  from holding Abbvie Inc or give up 9.32% of portfolio value over 90 days. Abbvie Inc is currently does not generate positive expected returns and assumes 1.5217% risk (volatility on return distribution) over the 90 days horizon. In different words, 13% of stocks are less volatile than Abbvie, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days Abbvie is expected to under-perform the market. In addition to that, the company is 1.26 times more volatile than its market benchmark. It trades about -0.09 of its total potential returns per unit of risk. The DOW is currently generating roughly -0.06 per unit of volatility.

Abbvie Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Abbvie's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Abbvie Inc, and traders can use it to determine the average amount a Abbvie's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0944

Good Returns
Average Returns
Small Returns
Negative ReturnsABBV
Estimated Market Risk
  actual daily
 13 %
of total potential
Expected Return
  actual daily
 0 %
of total potential
Risk-Adjusted Return
  actual daily
 0 %
of total potential
Based on monthly moving average Abbvie is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Abbvie by adding it to a well-diversified portfolio.

About Abbvie Performance

To evaluate Abbvie Inc Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Abbvie generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Abbvie Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Abbvie Inc market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Abbvie's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. Abbvie operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 50000 people.

Things to note about Abbvie Inc

Checking the ongoing alerts about Abbvie for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Abbvie Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Abbvie Alerts

Equity Alerts and Improvement Suggestions

Abbvie Inc generated a negative expected return over the last 90 days
The company currently holds 73.65 B in liabilities with Debt to Equity (D/E) ratio of 4.51, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Abbvie Inc has a current ratio of 0.82, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Abbvie until it has trouble settling it off, either with new capital or with free cash flow. So, Abbvie's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Abbvie Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Abbvie to invest in growth at high rates of return. When we think about Abbvie's use of debt, we should always consider it together with cash and equity.
About 71.0% of Abbvie shares are held by institutions such as insurance companies
On 15th of August 2022 Abbvie paid $ 1.41 per share dividend to its current shareholders
Latest headline from AbbVie, Rockwell Among 18 Companies To Announce Annual Dividend Increases In October - Seeking Alpha
Please continue to Trending Equities. Note that the Abbvie Inc information on this page should be used as a complementary analysis to other Abbvie's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for Abbvie Stock analysis

When running Abbvie Inc price analysis, check to measure Abbvie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbvie is operating at the current time. Most of Abbvie's value examination focuses on studying past and present price action to predict the probability of Abbvie's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abbvie's price. Additionally, you may evaluate how the addition of Abbvie to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Is Abbvie's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbvie. If investors know Abbvie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbvie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Abbvie Inc is measured differently than its book value, which is the value of Abbvie that is recorded on the company's balance sheet. Investors also form their own opinion of Abbvie's value that differs from its market value or its book value, called intrinsic value, which is Abbvie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbvie's market value can be influenced by many factors that don't directly affect Abbvie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbvie's value and its price as these two are different measures arrived at by different means. Investors typically determine Abbvie value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbvie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.